Rossby Financial’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$301 Sell
20
-20
-50% -$480 ﹤0.01% 2402
2026
Q2
$1.34K Buy
40
+1
+3% +$25 ﹤0.01% 1838
2026
Q1
$835 Buy
+39
New +$878 ﹤0.01% 2028

Other funds holding RARE

Rossby Financial's RARE Position: Q3 2026 in Review

Rossby Financial reduced its Ultragenyx Pharmaceutical (RARE) stake by 50% in Q3 2026, selling an estimated $480 and leaving 20 shares worth $301. The position accounts for ﹤0.01% of the portfolio, ranked #2402.

Rossby Financial first reported a position in RARE in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.34K in Q2 2026. 268 funds tracked by Wall St. Rank hold RARE as of Q3 2026.

  • Rossby Financial held 20 shares of Ultragenyx Pharmaceutical worth $301 as of Q3 2026.
  • Rossby Financial sold 20 Ultragenyx Pharmaceutical shares in Q3 2026, an estimated $480.
  • Ultragenyx Pharmaceutical made up ﹤0.01% of Rossby Financial's portfolio in Q3 2026, its #2402 holding.
  • Rossby Financial first reported a position in Ultragenyx Pharmaceutical in Q1 2026 and has held it in 3 quarters since.
  • Rossby Financial's Ultragenyx Pharmaceutical position peaked at $1.34K in Q2 2026.
  • 268 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q3 2026.

Based on Rossby Financial's 13F filing for Q3 2026, filed 5 Nov 2026.